# $hrow Harrow Inc. (HROW) sees mixed sentiment as some analysts highlight its eyecare growth story and potential, while others note sector-wide healthcare sell-offs impacting its stock price. ### About $hrow Harrow, Inc. is a pharmaceutical company focused on the ophthalmic market. ### Top $hrow Social Posts Top posts by engagements in the last [--] hours *Showing a maximum of [--] top social posts without a LunarCrush subscription.* "Bought full position $OCUL. 1st time I've invested in a biotech focused on the eye (past $HROW investment seemed more like a growth stock story to me). Ph3 data due this Q" [X Link](https://x.com/DeepSouthDoctor/status/2014745762979082383) [@DeepSouthDoctor](/creator/x/DeepSouthDoctor) 2026-01-23T17:03Z [----] followers, [----] engagements "@growthrapidly $ZETA $NBIS $HROW $NU $OSCR" [X Link](https://x.com/PedroLu29844268/status/2014627938302370282) [@PedroLu29844268](/creator/x/PedroLu29844268) 2026-01-23T09:15Z [--] followers, [---] engagements "@aincomeinvestor Do research find growth stocks that you think will significantly overperform and you will easily get there. I recommend looking into $inv $eose $hrow" [X Link](https://x.com/braden_tewinkel/status/2014580691766542545) [@braden_tewinkel](/creator/x/braden_tewinkel) 2026-01-23T06:07Z [---] followers, [---] engagements "One downside of not having a lot of tech stocks or AI data center names. its way harder to get followers 🥲 It makes me want to start a $NBIS and $ONDS position unironically. I'm not opposed to owning them. 🤷 Today big green +2.5% 🟢 for Ron Ron Pretty good considering im holding 20% cash right now after adjusting my positions. Trimmed some $PSNL and $TE after today's pump [--] new biotech positions $CRMD and $CLPT (3% each) $HROW under [--] is a easy buy for me even though I have a 8% https://t.co/SfyKcBKpL7 Today big green +2.5% 🟢 for Ron Ron Pretty good considering im holding 20% cash right" [X Link](https://x.com/Ron_Trades/status/2014502074822582623) [@Ron_Trades](/creator/x/Ron_Trades) 2026-01-23T00:54Z [---] followers, [---] engagements Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
Harrow Inc. (HROW) sees mixed sentiment as some analysts highlight its eyecare growth story and potential, while others note sector-wide healthcare sell-offs impacting its stock price.
Harrow, Inc. is a pharmaceutical company focused on the ophthalmic market.
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"Bought full position $OCUL. 1st time I've invested in a biotech focused on the eye (past $HROW investment seemed more like a growth stock story to me). Ph3 data due this Q"
X Link @DeepSouthDoctor 2026-01-23T17:03Z [----] followers, [----] engagements
"@growthrapidly $ZETA $NBIS $HROW $NU $OSCR"
X Link @PedroLu29844268 2026-01-23T09:15Z [--] followers, [---] engagements
"@aincomeinvestor Do research find growth stocks that you think will significantly overperform and you will easily get there. I recommend looking into $inv $eose $hrow"
X Link @braden_tewinkel 2026-01-23T06:07Z [---] followers, [---] engagements
"One downside of not having a lot of tech stocks or AI data center names. its way harder to get followers 🥲 It makes me want to start a $NBIS and $ONDS position unironically. I'm not opposed to owning them. 🤷 Today big green +2.5% 🟢 for Ron Ron Pretty good considering im holding 20% cash right now after adjusting my positions. Trimmed some $PSNL and $TE after today's pump [--] new biotech positions $CRMD and $CLPT (3% each) $HROW under [--] is a easy buy for me even though I have a 8% https://t.co/SfyKcBKpL7 Today big green +2.5% 🟢 for Ron Ron Pretty good considering im holding 20% cash right"
X Link @Ron_Trades 2026-01-23T00:54Z [---] followers, [---] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
/topic/$hrow